SCHEMBL25663345

SCHEMBL25663345

Nc1ccc(-c2ncnc3sc4ccccc4c23)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDR P35968 3/20 0.46
▸ LIMK1 P53667 4/20 0.41
▸ CDK5 Q00535 1/20 0.41
▸ CDK5R1 Q15078 1/20 0.41
▸ ALDH1A1 P00352 2/20 0.39
▸ MAPT P10636 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ APP P05067 3/20 0.39
▸ MMP9 P14780 1/20 0.39
▸ MMP8 P22894 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ KIT P10721 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18370866 0.88 ADORA2A (0.47) KDRLIMK1CDK5CDK5R1ALDH1A1
SCHEMBL24795729 0.81 LIMK1 (0.37) KDRLIMK1CDK5CDK5R1ALDH1A1
SCHEMBL924654 0.78 LIMK1 (0.56) KDRLIMK1CDK5CDK5R1ALDH1A1
SCHEMBL25663123 0.74 APP (0.50) KDRALDH1A1MAPTRAB9ASMN1; SMN2
SCHEMBL25841452 0.73 PRKD3 (0.39) LIMK1CDK5CDK5R1ALDH1A1MAPT
SCHEMBL25663116 0.73 TGFBR1 (0.33) LIMK1ALDH1A1CYP1A2CYP3A4MEN1
SCHEMBL18471422 0.73 KDM4E (0.39) LIMK1ALDH1A1MAPTKDM4EATM
SCHEMBL25663098 0.72 RAB9A (0.39) ALDH1A1MAPTHPGDRAB9ASMN1; SMN2
SCHEMBL25663101 0.72 PIK3CA (0.48) KDR
SCHEMBL25663117 0.72 PIK3CD (0.34) LIMK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2023-06-01 — — US disclosed
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2023-06-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE CHRM1, CHRM2, CHRM4 KDR 2970/4885LIMK1 1044/4885CDK5 1467/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback